We have been waiting a long time for a Board of Appeal to finally refer questions to the Enlarged Board on the long-running controversy of whether, or to what extent, amendments to the description are required for European patents and patent applications. Given recent developments, we may now be getting near the point where this actually happens.
In brief, the issue of description amendments is, as far as the EPO is concerned, a settled matter. In their view it is necessary for the description to be in line with the claims to avoid any inconsistencies. According to the current version of the Guidelines for Examination, F-IV, 4.3, "The applicant must remove any inconsistencies by amending the description either by deleting the inconsistent embodiments or marking appropriately so that it is clear that they do not fall within the subject-matter for which protection is sought". In many cases, this leads to extra time and trouble being expended when attempting to get an application allowed. Many have also objected that the supposed justification for this requirement simply is not there in the EPC. Article 84, which is used by the EPO in support, simply requires the claims to be "clear and concise and be supported by the description". If the description provides support for the claimed invention, does it even matter if it also includes support for things that are not part of the claimed invention? There are also cases where it may not be clear where the line should be drawn between what is described in the application as a whole as embodiments and what is actually within the scope of the claimed invention. Forcing applicants, and their attorneys, to make a decision during prosecution that can affect how the invention may be interpreted post-grant (since courts invariably insist that the description is always used to interpret the claims) may be considered unfair, if not actually unjust.
Those of us who have been keeping a close eye on this thought that we were going to get a referral last from the appeal case of T 56/21. In the end, however, the Board decided that a referral was not needed because in their view Article 84 did not provide any justification for amendments to the description at all. I wrote last year about this lengthy decision here. The EPO, however, has been taking no notice at all of the decision (which is, of course, only binding on the case in question) and maintains that their practice is justified. The Guidelines therefore remain unchanged.
However, in another appeal case, T 697/22, there has been some movement on the matter. Following oral proceedings held in December 2024, the Board indicated that they were minded to refer questions to the Enlarged Board. A communication has recently issued with some proposed questions, which the Board has asked the parties involved to comment on before they make a decision on a referral. Unlike in T 56/21, the Board found that there was divergent case law on the subject of description amendments and a referral may be needed to resolve the question of whether these were in fact required. The proposed questions are the following:
1. If the claims of a European patent are amended during opposition proceedings or opposition-appeal proceedings, and the amendments introduce an inconsistency between the amended claims and the description of the patent, is it necessary to comply with the requirements of the EPC, to adapt the description to the amended claims such that the inconsistency is removed?
2. If the first question is unconditionally answered in the affirmative, which requirement of the EPC necessitates such an adaptation?
3. If the first question cannot be unconditionally answered in the affirmative, what are the conditions under which adaptation of the description is necessary to comply with the requirements of the EPC?
4. Would the answer to these questions change if an inconsistency existed between the claims and the description of a European patent application?
The parties have been given until 26 May 2025 to provide comments, following which the Board will decide whether a referral is to be made, and if so what the final form of the questions should be.
For now, all we can do is wait and see what happens. It is, however, interesting to note that the draft questions avoid mentioning Article 84 EPC at all. This is clearly deliberate, since question 2 asks whether there is any provision in the EPC that requires the description to be adapted to the claims. If T 56/21 is to be followed, there is in fact no such provision. The Enlarged Board, however, may find differently.
Thanks! I don't get the fourth question. Does it ask about how to treat discrepancies in the patent as granted during opposition ?
ReplyDeleteI think the fourth question just asks if the principles change in any way in relation to pre-grant rather than post-grant.
DeleteSo in your view, Q4 basically asks, for Q1: " If the claims of a European patent are amended during proceedings, and the amendments introduce an inconsistency between the amended claims and the description of the , is it necessary to comply with the requirements of the EPC, to adapt the description to the amended claims such that the inconsistency is removed?"
DeleteI guess the EBA could answer this question as well, although not necessary for the underlying appeal, if they wish. In fact, if the EBA wishes to extend the legal reasoning from the case at hand (opposition) to pre-grant amendments, they can, without the need for a specific question of the TBA.
I thought Q4 may also mean whether G3/14 prohibits the Board in opposition appeal (and the OD) from raising any issues that already existed in the claims as granted.
Plu, it is fair to say that both Q1 and Q4 are poorly worded.
DeleteIf the Board truly had an open mind regarding the possible legal basis for adaptation of the description, then they would not have limited Q1 such that it only concerns opposition proceedings in which Art 84 EPC is in play.
Also, if the Board truly wanted to understand the legal basis for PRE-grant adaptation of the description, it should not have limited Q1 as described above.
If Q4 is to be interpreted as relating to pre-grant proceedings (as opposed to being interpreted in the manner that you proposed), then it is hard to see how that question could be admissible ... as an answer to that question is clearly not required to resolve the case underpinning the referral.
Q4 relates to the limitations imposed by G3/14 and thus explicitly addresses the possibility that Art. 84 EPC is the basis for requiring adaptation of the description.
ReplyDeleteIn this regard, it is interesting to see that Q1 is also limited to opposition (appeal) proceedings. That seems unnecessarily narrow. If there is any legal basis for adaptation of the description, then that surely also applies to pre-grant proceedings.
Perhaps the parties will point this out in their observations. However, I rather suspect that the wording of Q1 might provide the EBA with an excuse to limit their answer accordingly, and for the EPO to carry on with their current PRE-grant practice regardless of the EBA's decision. After all, this is precisely how the EPO has responded to the EBA's (similarly limited) decision in G1/21.
Another thing to watch out for: will there be any suspension / interruption of proceedings where an OD's or a Board of Appeal's decision depends entirely upon the EBA's decision? Recent history with G1/21 and G1/24 suggests not. But could this be a reason why the Board has proposed limiting Q1 to opposition (appeal) proceedings only?
Apologies for the delay in approving comments (I don't usually get very many), and thank you for the useful input!
ReplyDelete